Testosterone Replacement Therapy in Men with Prostate Cancer: What Is the Evidence?. Issue 3 (23rd September 2013)
- Record Type:
- Journal Article
- Title:
- Testosterone Replacement Therapy in Men with Prostate Cancer: What Is the Evidence?. Issue 3 (23rd September 2013)
- Main Title:
- Testosterone Replacement Therapy in Men with Prostate Cancer: What Is the Evidence?
- Authors:
- Selph, J. Patrick
Carson, Culley C. - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <sec id="smrj15-sec-2001" sec-type="section"> <title>Introduction</title> <p>Testosterone is increasingly being recognized as an important hormone in maintaining proper health in aging males. Testosterone replacement therapy in older men with decreased or low‐normal testosterone levels has been recognized to improve sexual function, increase lean body mass and decrease fat mass, improve exercise‐induced coronary ischemia, and elevate mood, among other benefits. Prostate cancer remains the most common non‐skin malignancy in men in the United States, and as hypogonadism is being recognized and treated more, a dilemma has arisen: treating hypogonadism in men previously treated for prostate cancer. While testosterone replacement has traditionally been felt to be contraindicated in men with prostate cancer, recent studies have challenged this notion.</p> </sec> <sec id="smrj15-sec-2002" sec-type="section"> <title>Aim</title> <p>This review highlights the origins of this concern as well as newer data that suggest that testosterone replacement in men with prostate cancer is safe.</p> </sec> <sec id="smrj15-sec-2003" sec-type="section"> <title>Methods</title> <p>A literature search on testosterone replacement therapy in men with prostate cancer was performed.</p> </sec> <sec id="smrj15-sec-1001" sec-type="section"> <title>Main Outcome Measure</title> <p>We sought to highlight the data supporting the use of testosterone in men<abstract abstract-type="main"> <title>Abstract</title> <sec id="smrj15-sec-2001" sec-type="section"> <title>Introduction</title> <p>Testosterone is increasingly being recognized as an important hormone in maintaining proper health in aging males. Testosterone replacement therapy in older men with decreased or low‐normal testosterone levels has been recognized to improve sexual function, increase lean body mass and decrease fat mass, improve exercise‐induced coronary ischemia, and elevate mood, among other benefits. Prostate cancer remains the most common non‐skin malignancy in men in the United States, and as hypogonadism is being recognized and treated more, a dilemma has arisen: treating hypogonadism in men previously treated for prostate cancer. While testosterone replacement has traditionally been felt to be contraindicated in men with prostate cancer, recent studies have challenged this notion.</p> </sec> <sec id="smrj15-sec-2002" sec-type="section"> <title>Aim</title> <p>This review highlights the origins of this concern as well as newer data that suggest that testosterone replacement in men with prostate cancer is safe.</p> </sec> <sec id="smrj15-sec-2003" sec-type="section"> <title>Methods</title> <p>A literature search on testosterone replacement therapy in men with prostate cancer was performed.</p> </sec> <sec id="smrj15-sec-1001" sec-type="section"> <title>Main Outcome Measure</title> <p>We sought to highlight the data supporting the use of testosterone in men with prostate cancer.</p> </sec> <sec id="smrj15-sec-2004" sec-type="section"> <title>Results</title> <p>While no randomized controlled trials have been able to confirm this theory, data from multiple studies suggest that testosterone replacement is safe in selected men treated for prostate cancer.</p> </sec> <sec id="smrj15-sec-2005" sec-type="section"> <title>Conclusion</title> <p>Long‐term data and more studies are needed to conclusively change the paradigm regarding testosterone and prostate cancer growth, but based on the current data and on our experience, we feel it is safe to prescribe testosterone replacement therapy to men treated for prostate cancer with favorable pathology. <bold>Selph JP and Carson CC. Testosterone replacement therapy in men with prostate cancer: What is the evidence? Sex Med Rev 2013;1:135–142.</bold></p> </sec> </abstract> … (more)
- Is Part Of:
- Sexual medicine reviews. Volume 1:Issue 3(2013:Oct.)
- Journal:
- Sexual medicine reviews
- Issue:
- Volume 1:Issue 3(2013:Oct.)
- Issue Display:
- Volume 1, Issue 3 (2013)
- Year:
- 2013
- Volume:
- 1
- Issue:
- 3
- Issue Sort Value:
- 2013-0001-0003-0000
- Page Start:
- 135
- Page End:
- 142
- Publication Date:
- 2013-09-23
- Subjects:
- Sexual disorders -- Periodicals
616.69005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/20500521 ↗
https://academic.oup.com/smr ↗
http://onlinelibrary.wiley.com/ ↗
http://www.issm.info/journals1/sexual-medicine-reviews1/ ↗ - DOI:
- 10.1002/smrj.15 ↗
- Languages:
- English
- ISSNs:
- 2050-0513
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8254.484470
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3754.xml